Literature DB >> 22127554

Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus.

Marta Vadacca1, Enrico M Zardi, Domenico Margiotta, Amelia Rigon, Fabio Cacciapaglia, Luisa Arcarese, Francesca Buzzulini, Antonio Amoroso, Antonella Afeltra.   

Abstract

The purpose of the present study was to determine levels of adipokines and their relationship with stiffness parameters and disease activity index in SLE patients in comparison with healthy controls. Sixty SLE patients and 29 control subjects were enrolled in the study. Serum leptin and adiponectin levels were determined by commercial sandwich ELISA kits. Colour-coded carotid duplex sonography was performed using a Siemens SONOLINE Antares machine equipped with linear 5-13 MHz. SLEDAI, ECLAM and SLICC were evaluated in all patients. Data were analysed by software for statistical analysis (Prism 5.0). Median leptin is higher among SLE patients compared with controls (p 0.035). Median values of vascular stiffness and PSEM are increased in SLE compared with controls (p = 0.0003 and p = 0.007). Vascular strain and vascular distensibility are lower in SLE patients in comparison with controls (p = 0.0001 and p = 0.0006, respectively). Considering SLE patients, leptin levels correlate with vascular stiffness (r = 0.64, p < 0.0001) and PSEM (r = 0.63, p < 0.0001). Adiponectin levels correlate with vascular strain (r = 0.28, p 0.039) and negatively correlate with vascular stiffness (r = -0.38, p 0.039). Leptin levels correlate with disease activity (SLEDAI and ECLAM) and cumulative damage (SLICC) indexes. This study demonstrates higher values of leptin in SLE patients. Moreover, SLE patients show increased levels of vascular stiffness and PSEM and reduced values of vascular strain and distensibility. These results globally indicate a decline in arterial elasticity. We find a positive correlation of leptin with stiffness parameters. According to its atheroprotective action, adiponectin inversely correlates with stiffness parameters.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22127554     DOI: 10.1007/s11739-011-0726-0

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  38 in total

Review 1.  Adipokines: the missing link between insulin resistance and obesity.

Authors:  B Antuna-Puente; B Feve; S Fellahi; J-P Bastard
Journal:  Diabetes Metab       Date:  2008-02       Impact factor: 6.041

2.  The cardiovascular threat of lupus.

Authors:  Joan M Von Feldt
Journal:  Nat Clin Pract Rheumatol       Date:  2008-10

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 4.  Role of leptin in blood pressure regulation and arterial hypertension.

Authors:  Jerzy Bełtowski
Journal:  J Hypertens       Date:  2006-05       Impact factor: 4.844

5.  Abnormal mechanical properties of larger arteries in postmenopausal women with systemic lupus erythematosus.

Authors:  J Brodszki; C Bengtsson; T Länne; O Nived; G Sturfelt; K Marsál
Journal:  Lupus       Date:  2004       Impact factor: 2.911

6.  Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.

Authors:  Mary J Roman; Beth-Ann Shanker; Adrienne Davis; Michael D Lockshin; Lisa Sammaritano; Ronit Simantov; Mary K Crow; Joseph E Schwartz; Stephen A Paget; Richard B Devereux; Jane E Salmon
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

7.  Association between insulin, leptin, adiponectin and blood pressure in youth.

Authors:  Marie Lambert; Jennifer O'Loughlin; Edgard E Delvin; Emile Levy; Arnaud Chiolero; Gilles Paradis
Journal:  J Hypertens       Date:  2009-05       Impact factor: 4.844

8.  Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus.

Authors:  Maureen McMahon; Jennifer Grossman; Brian Skaggs; John Fitzgerald; Lori Sahakian; Nagesh Ragavendra; Christina Charles-Schoeman; Karol Watson; Weng Kee Wong; Elizabeth Volkmann; Weiling Chen; Alan Gorn; George Karpouzas; Michael Weisman; Daniel J Wallace; Bevra H Hahn
Journal:  Arthritis Rheum       Date:  2009-08

9.  Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus.

Authors:  Q Shang; L S Tam; E K M Li; G W K Yip; C M Yu
Journal:  Lupus       Date:  2008-12       Impact factor: 2.911

10.  High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids.

Authors:  Maureen McMahon; Brian J Skaggs; Lori Sahakian; Jennifer Grossman; John FitzGerald; Nagesh Ragavendra; Christina Charles-Schoeman; Marissa Chernishof; Alan Gorn; Joseph L Witztum; Weng Kee Wong; Michael Weisman; Daniel J Wallace; Antonio La Cava; Bevra H Hahn
Journal:  Ann Rheum Dis       Date:  2011-06-13       Impact factor: 19.103

View more
  13 in total

1.  Serum adipokine levels and associations with patient-reported fatigue in systemic lupus erythematosus.

Authors:  Mary A Mahieu; Grace E Ahn; Joan S Chmiel; Dorothy D Dunlop; Irene B Helenowski; Pamela Semanik; Jing Song; Susan Yount; Rowland W Chang; Rosalind Ramsey-Goldman
Journal:  Rheumatol Int       Date:  2018-01-04       Impact factor: 2.631

Review 2.  Sex differences in mechanisms of arterial stiffness.

Authors:  Jennifer J DuPont; Rachel M Kenney; Ayan R Patel; Iris Z Jaffe
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

Review 3.  Metabolic determinants of lupus pathogenesis.

Authors:  Xiangyu Teng; Josephine Brown; Seung-Chul Choi; Wei Li; Laurence Morel
Journal:  Immunol Rev       Date:  2020-03-12       Impact factor: 12.988

Review 4.  Why are kids with lupus at an increased risk of cardiovascular disease?

Authors:  Catherine Quinlan; Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2015-09-23       Impact factor: 3.714

Review 5.  Adiponectin: a therapeutic target in the antiphospholipid syndrome?

Authors:  Mirjana B Bećarević; Božana S Nikolić; Svetlana D Ignjatović
Journal:  Rheumatol Int       Date:  2019-06-18       Impact factor: 2.631

Review 6.  Emerging role of leptin in rheumatoid arthritis.

Authors:  G Tian; J-N Liang; Z-Y Wang; D Zhou
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

Review 7.  Emerging role of adipokines in systemic lupus erythematosus.

Authors:  Hong-Miao Li; Tian-Ping Zhang; Rui-Xue Leng; Xiang-Pei Li; Xiao-Mei Li; Hai-Rong Liu; Dong-Qing Ye; Hai-Feng Pan
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

8.  Biological Pathways in Adolescent Aortic Stiffness.

Authors:  Justin P Zachariah; Yunfei Wang; Jane W Newburger; Sarah D deFerranti; Gary F Mitchell; Ramachandran S Vasan
Journal:  J Am Heart Assoc       Date:  2021-03-01       Impact factor: 5.501

Review 9.  Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases.

Authors:  Morena Scotece; Javier Conde; Rodolfo Gómez; Verónica López; Jesús Pino; Antonio González; Francisca Lago; Juan J Gómez-Reino; Oreste Gualillo
Journal:  Mediators Inflamm       Date:  2012-07-15       Impact factor: 4.711

10.  Adipokine gene expression in peripheral blood of adult and juvenile dermatomyositis patients and their relation to clinical parameters and disease activity measures.

Authors:  Jeannette M Olazagasti; Molly Hein; Cynthia S Crowson; Consuelo Lopez de Padilla; Erik Peterson; Emily C Baechler; Ann M Reed
Journal:  J Inflamm (Lond)       Date:  2015-04-09       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.